Atrial cardiomyopathy (ACMP) is a structural, electrical, or contractile disorder of the atria that may lead to clinical manifestation. ACMP may manifest as:
ACMP creates the substrate (trigger and substrate) for atrial fibrillation (AF):
| Atrial cardiomyopathy |
|---|
| Atrial cardiomyopathy (ACMP) is a structural, electrical, or contractile disorder of the atria that may lead to clinical manifestation. ACMP most commonly manifests as atrial fibrillation. |
ACMP develops due to risk factors: age, arterial hypertension, obesity, heart failure, alcohol, AF.
If AF occurs in young individuals (<45 years) without risk factors and without structural heart disease, the substrate for AF most likely developed due to ACMP of genetic origin.
ACMP is present in
ACMP has 3 stages
| Atrial cardiomyopathy and atrial fibrillation | ||
|---|---|---|
| Stage of ACMP | Atrial changes (structural, mechanical, electrical) | Clinical manifestation of ACMP |
| 1. Subclinical ACMP |
|
|
| 2. Clinical ACMP |
|
|
| 3. Advanced ACMP |
|
|
The examinations that demonstrate the given pathological atrial change are indicated in parentheses.
ACMP – Atrial cardiomyopathy, CMR – Cardiac magnetic resonance imaging, EPS – Electrophysiological study, TTE – Transthoracic echocardiography, ECG – Electrocardiography, EF – Ejection fraction, TEE – Transesophageal echocardiography, LA – Left atrium, AF – Atrial fibrillation, LAA – Left atrial appendage
ECG changes in clinical or advanced ACMP (in sinus rhythm):
These guidelines are unofficial and do not represent formal guidelines issued by any professional cardiology society. They are intended for educational and informational purposes only.